VALUE AND LIMITATIONS OF CUTTING-EDGE SCIENCE (E.G, PHARMACOGENOMICS AND POPULATION PHARMACODYNAMIC ANALYSIS) TO PATIENT CARE HERE AND NOW
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Presentation
- By: IEIRI, Ichiro (Kyushu University, Clinical Pharmacokinetics, Fukuoka, Japan)
- Co-author(s): Ichiro Ieiri
In my presentation, I will talk about utility of cutting-edge science, such as pharmacogenomic (PGx) information and population pharmacodynamic (PPD) analysis, at patient care. Currently in Japan, PGx is incorporated into patient care; for example, highly advanced medical treatment (HAMT). The HAMT is the Japanese medical system to provide high.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.